Cellular Dynamics International Presents Annual iForumSM Meetings Focused on New Applications and Uses for Differentiated Human iPS Cells

Dynamics International (CDI), a FUJIFILM company
, today announced
that it will host the iForumSM 2017 meetings at The Buck
Institute (Novato, CA) on September 14, 2017, Harvard Medical School
(Boston, MA) on September 21, 2017, and at Imperial College (London,
U.K.) on September 28, 2017. The annual iForum SM meetings
provide attendees with an opportunity to connect with thought leaders
from academia, government, biotech, and pharma to discover new
applications and innovative uses for differentiated induced pluripotent
stem cells (iPSC) through interactive, data-driven presentations.

“iPSCs and differentiated iPSCs have become vital in initiatives
directed at disease modeling, drug screening initiatives, toxicity
testing, regenerative medicine and more,” said Dr. Bruce E. Novich,
Division President-CNBD for FUJIFILM Holdings America Corporation and
Division President, Life Science Division of Cellular Dynamics
International, a FUJIFILM company. “At the iForumSM 2017
meetings, global leaders in the stem cell community will convene to
share how these cells are ushering in a new era of drug and therapeutics

During this premier stem cell event, key opinion leaders will present
their insights, investigations, and future plans for utilizing iPSCs in
experimental designs. Keynote speakers include:

  • Chad Cowan, PhD, Harvard Department of Stem Cell and Regenerative
    Biology, Massachusetts General Hospital [iForumSM Novato]
  • Donald E. Ingber, MD, PhD, Wyss Institute for Biologically Inspired
    Engineering at Harvard University [iForumSM Boston]
  • Sian Harding, PhD, Professor of Cardiac Pharmacology, Faculty of
    Medicine, National Heart & Lung Institute, Imperial College of London
    [iForumSM London]

In addition to educational keynotes from the industry’s leading
professionals, the meeting will include scientific talks, poster
sessions, and networking. Featured topics will include complex models
and regenerative medicine, disease modeling and drug discovery, and
predictive toxicology.

For more information or to register to attend one of the iForumSM
2017 meetings, please visit: https://iforum.community/

About Cellular Dynamics International, a FUJIFILM company

Cellular Dynamics International, a FUJIFILM company, is a leading
developer and supplier of human cells used in drug discovery, toxicity
testing, and regenerative medicine applications. Leveraging technology
that can be used to create induced pluripotent stem cells (iPSCs) and
differentiated tissue-specific cells from any individual, CDI is
committed to advancing life science research and transforming the
therapeutic development process in order to fundamentally improve human
health. The company’s inventoried iCell® products and donor-specific
MyCell® Products are available in the quantity, quality, purity, and
reproducibility required for drug and cell therapy development. For more
information please visit www.cellulardynamics.com.

About Fujifilm

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation
and leading-edge products to a broad spectrum of industries, including:
healthcare, with medical systems, pharmaceuticals and cosmetics; graphic
systems; highly functional materials, such as flat panel display
materials; optical devices, such as broadcast and cinema lenses; digital
imaging; and document products. These are based on a vast portfolio of
chemical, mechanical, optical, electronic, software and production
technologies. In the year ended March 31, 2017, the company had global
revenues of $21.5 billion, at an exchange rate of 108 yen to the dollar.
Fujifilm is committed to environmental stewardship and good corporate
citizenship. For more information, please visit: www.fujifilmholdings.com.

All product and company names herein may be trademarks of their
registered owners.


Lauren Geloso, (914) 789-8303